Schizophrenia — An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Citation(s)
A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia